479 related articles for article (PubMed ID: 32295432)
1. Panaxynol from
Sun X; Zhang T; Zhao Y; Cai E; Zhu H; Liu S
Biotech Histochem; 2020 Nov; 95(8):575-583. PubMed ID: 32295432
[TBL] [Abstract][Full Text] [Related]
2. Isovitexin alleviates liver injury induced by lipopolysaccharide/d-galactosamine by activating Nrf2 and inhibiting NF-κB activation.
Hu JJ; Wang H; Pan CW; Lin MX
Microb Pathog; 2018 Jun; 119():86-92. PubMed ID: 29604422
[TBL] [Abstract][Full Text] [Related]
3. Hepatoprotective effect of chiisanoside from Acanthopanax sessiliflorus against LPS/D-GalN-induced acute liver injury by inhibiting NF-κB and activating Nrf2/HO-1 signaling pathways.
Bian X; Liu X; Liu J; Zhao Y; Li H; Zhang L; Li P; Gao Y
J Sci Food Agric; 2019 May; 99(7):3283-3290. PubMed ID: 30552777
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.
Liu MW; Liu R; Wu HY; Zhang W; Xia J; Dong MN; Yu W; Wang Q; Xie FM; Wang R; Huang YQ; Qian CY
Int J Mol Med; 2016 Nov; 38(5):1419-1432. PubMed ID: 27666960
[TBL] [Abstract][Full Text] [Related]
5. Protective Effects of Sesquiterpenoids from the Root of Panax ginseng on Fulminant Liver Injury Induced by Lipopolysaccharide/d-Galactosamine.
Wang W; Zhang Y; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
J Agric Food Chem; 2018 Jul; 66(29):7758-7763. PubMed ID: 29974747
[TBL] [Abstract][Full Text] [Related]
6. Madecassoside prevents acute liver failure in LPS/D-GalN-induced mice by inhibiting p38/NF-κB and activating Nrf2/HO-1 signaling.
Wang W; Wu L; Li Q; Zhang Z; Xu L; Lin C; Gao L; Zhao K; Liang F; Zhang Q; Zhou M; Jiang W
Biomed Pharmacother; 2018 Jul; 103():1137-1145. PubMed ID: 29715757
[TBL] [Abstract][Full Text] [Related]
7. Study on the antidepressant effect of panaxynol through the IκB-α/NF-κB signaling pathway to inhibit the excessive activation of BV-2 microglia.
Zhao Y; Sun X; Zhang T; Liu S; Cai E; Zhu H
Biomed Pharmacother; 2021 Jun; 138():111387. PubMed ID: 33721753
[TBL] [Abstract][Full Text] [Related]
8. Hepatoprotective effect of α-mangostin against lipopolysaccharide/d-galactosamine-induced acute liver failure in mice.
Fu T; Li H; Zhao Y; Cai E; Zhu H; Li P; Liu J
Biomed Pharmacother; 2018 Oct; 106():896-901. PubMed ID: 30119260
[TBL] [Abstract][Full Text] [Related]
9. Andrographolide ameliorates d-galactosamine/lipopolysaccharide-induced acute liver injury by activating Nrf2 signaling pathway.
Pan CW; Yang SX; Pan ZZ; Zheng B; Wang JZ; Lu GR; Xue ZX; Xu CL
Oncotarget; 2017 Jun; 8(25):41202-41210. PubMed ID: 28465482
[TBL] [Abstract][Full Text] [Related]
10. Maslinic acid protects against lipopolysaccharide/d-galactosamine-induced acute liver injury in mice.
Wang YY; Diao BZ; Zhong LH; Lu BL; Cheng Y; Yu L; Zhu LY
Microb Pathog; 2018 Jun; 119():49-53. PubMed ID: 29627448
[TBL] [Abstract][Full Text] [Related]
11. Rosmarinic acid protects mice from lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting MAPKs/NF-κB and activating Nrf2/HO-1 signaling pathways.
Li Z; Feng H; Wang Y; Shen B; Tian Y; Wu L; Zhang Q; Jin M; Liu G
Int Immunopharmacol; 2019 Feb; 67():465-472. PubMed ID: 30597292
[TBL] [Abstract][Full Text] [Related]
12. Protective effects of morin on lipopolysaccharide/d-galactosamine-induced acute liver injury by inhibiting TLR4/NF-κB and activating Nrf2/HO-1 signaling pathways.
Tian Y; Li Z; Shen B; Zhang Q; Feng H
Int Immunopharmacol; 2017 Apr; 45():148-155. PubMed ID: 28213269
[TBL] [Abstract][Full Text] [Related]
13. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K
Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120
[TBL] [Abstract][Full Text] [Related]
14. Protective effects of alpinetin on lipopolysaccharide/d-Galactosamine-induced liver injury through inhibiting inflammatory and oxidative responses.
Liu TG; Sha KH; Zhang LG; Liu XX; Yang F; Cheng JY
Microb Pathog; 2019 Jan; 126():239-244. PubMed ID: 30414839
[TBL] [Abstract][Full Text] [Related]
15. Nobiletin attenuates lipopolysaccharide/D‑galactosamine‑induced liver injury in mice by activating the Nrf2 antioxidant pathway and subsequently inhibiting NF‑κB‑mediated cytokine production.
He Z; Li X; Chen H; He K; Liu Y; Gong J; Gong J
Mol Med Rep; 2016 Dec; 14(6):5595-5600. PubMed ID: 27878238
[TBL] [Abstract][Full Text] [Related]
16. Downregulated microRNA-27b attenuates lipopolysaccharide-induced acute lung injury via activation of NF-E2-related factor 2 and inhibition of nuclear factor κB signaling pathway.
Huang Y; Huang L; Zhu G; Pei Z; Zhang W
J Cell Physiol; 2019 May; 234(5):6023-6032. PubMed ID: 30584668
[TBL] [Abstract][Full Text] [Related]
17. Costunolide protects lipopolysaccharide/d-galactosamine-induced acute liver injury in mice by inhibiting NF-κB signaling pathway.
Wang Y; Zhang X; Zhao L; Shi M; Wei Z; Yang Z; Guo C; Fu Y
J Surg Res; 2017 Dec; 220():40-45. PubMed ID: 29180209
[TBL] [Abstract][Full Text] [Related]
18. Endotoxin tolerance ameliorates lipopolysaccharide/D-galactosamine-induced acute liver failure by negative regulation of the NF-κB/NLRP3 and activation of Nrf2/HO-1 via Sitr1.
Shi H; Xie X; Zheng S; Chen H; Liu C; Li S; Lu M
Int Immunopharmacol; 2024 May; 132():111994. PubMed ID: 38581992
[TBL] [Abstract][Full Text] [Related]
19. Biochanin A protects lipopolysaccharide/D-galactosamine-induced acute liver injury in mice by activating the Nrf2 pathway and inhibiting NLRP3 inflammasome activation.
Liu X; Wang T; Liu X; Cai L; Qi J; Zhang P; Li Y
Int Immunopharmacol; 2016 Sep; 38():324-31. PubMed ID: 27344638
[TBL] [Abstract][Full Text] [Related]
20. Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice.
Liu A; Shen Y; Du Y; Chen J; Pei F; Fu W; Qiao J
Microb Pathog; 2018 Dec; 125():418-422. PubMed ID: 30290266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
